American Society of Hematology

Committee on Promoting Diversity

Committee Roster

Chair
Christopher Flowers, MD,MS ('20)

Vice Chair
Deirdra Terrell, PhD ('20)

Appointed Members
Staci D. Arnold, MD, MBA, MPH ('21)
Rafael Bejar, MD, PhD ('21)
Leon Bernal-Mizrachi, MD ('22)
Deepika S. Darbari, MD ('20)
Alex Francisco Herrera, MD ('19)
Ruben A. Mesa, MD ('19)
Sudipto Mukherjee, MD, PhD, MPH ('19)
Natarajan Muthusamy, DVM,PhD ('20)
Betty Pace, MD ('19)
Tycel J. Phillips, MD ('21)
Willye B. Powell, MD ('19)
Rayne H. Rouce, MD ('22)
Melody Smith, MD ('22)
Alison R. Walker, MD ('20)

Ex Officio Members
Stephanie J. Lee, MD, MPH ('20) - President-Elect
Roy L. Silverstein, MD ('19) - President
Martin S. Tallman, MD ('21) - Vice President

Liaisons
Cage Saul Johnson, MD ('21) - Member, Nominating Committee
Arturo Molina, MD,MS, FACP - ASH Representative to AMFDP NAC

Staff Liaison
Patricia Frustace

Committee Mandate

The Committee on Promoting Diversity is responsible for advising ASH in its efforts to improve minority recruitment into hematology research and practice in the United States and Canada, attract minority hematologists as members of the Society, and develop minority hematologists as leaders.

 

The Committee on Promoting Diversity oversees all aspects of the Minority Medical Student Award Program (MMSAP), the Minority Graduate Student Abstract Achievement Award (MGSAAA), and the Minority Resident Hematology Award Program (MRHAP), including the selection of applicants for participation, mentor identification, and program evaluation, as well as the ASH-AMFDP – a partnership between ASH and the Harold Amos Medical Faculty Development Program (AMFDP) of the Robert Wood Johnson Foundation.  Finally, the Committee is responsible for the oversight of the MRI Programs Subcommittee.

 

The Committee on Promoting Diversity monitors ASH programs, products, and services and makes recommendations to the ASH Executive Committee for modifications to benefit the Society’s membership – such as the newly established ASH Institutional Representative Program.  The Committee is also responsible for ensuring minority representation across the Society.  This includes, but is not limited to, making suggestions for potential abstract reviewers, speakers, and committee appointments.

 

The Committee on Promoting Diversity sponsors the Promoting Minorities in Hematology event, which is held during the ASH annual meeting.  This event, along with the MMSAP Luncheon, also sponsored by the Committee, provides minority hematologists and trainees with networking opportunities.

 

The Committee on Promoting Diversity structure includes at least two ASH members who have a PhD designation (to ensure that the interests of this constituency are represented) and a Nominating Committee member as a liaison member. There is also a liaison position for the ASH representative to the AMFDP National Advisory Committee.

 

Members of the Committee on Promoting Diversity are required to attend two meetings per year: one in the spring at ASH Headquarters and one in the fall at ASH Headquarters.

 

The Chair of the Committee on Promoting Diversity serves as a liaison member of the Program Committee and is expected to attend the meetings of that committee.

 

A member of the Committee on Promoting Diversity serves as a liaison member to the Awards Committee and is expected to attend the meetings of that committee.

 

MRI Study Section

The voting members of the Committee on Promoting Diversity (i.e. appointed members and liaisons but not ex-officio members or representatives) serve as the Minority Recruitment Initiative (MRI) Study Section.  The study section reviews applications, provides critiques and/or feedback as appropriate, and makes recommendations for recipients of the Minority Medical Student Award Program (MMSAP) and the Minority Resident Hematology Award Program (MRHAP).  The Committee on Promoting Diversity makes funding recommendations to the ASH Executive Committee which serves as the ultimate arbiter for questions from the study section related to eligibility.

 

ASH study section members should have a broad knowledge of the field of hematology in order to adequately contribute to deliberations regarding applicantsComposition is determined by the study section chair based on the following considerations:

 

·         the relevant pool of applicants/nominees;

·         the self-declared subject matter expertise of the volunteers;

·         volunteer eligibility; and

·         study section diversity (i.e. gender, institution, geography, race and ethnicity).

 

As needed, ad hoc reviewers (individuals from the approved list of ASH members eligible to serve on an ASH study section) serve on the study section.

 

Study section members are required to adhere to deadlines, follow review instructions, and handle tasks via the ASH online award system.  The study section review culminates in a discussion that may be in-person at ASH Headquarters or via conference call.  Study section members are required to participate in the discussion, adhering to the ASH Conflict of Interest Policy and relevant procedures.  Commitments for the MRI Study Section generally occur in the late winter (e.g., January and February).

back to top